Literature DB >> 22819214

Slower postnatal motor development in infants of mothers with latent toxoplasmosis during the first 18 months of life.

Sárka Kaňková1, Jan Sulc, Romana Křivohlavá, Aleš Kuběna, Jaroslav Flegr.   

Abstract

Toxoplasmosis, a zoonosis caused by a protozoan, Toxoplasma gondii, is probably the most widespread human parasitosis in developed countries. Pregnant women with latent toxoplasmosis have seemingly younger fetuses especially in the 16th week of gestation, which suggests that fetuses of Toxoplasma-infected mothers have slower rates of development in the first trimester of pregnancy. In the present retrospective cohort study, we analyzed data on postnatal motor development of infants from 331 questionnaire respondents including 53 Toxoplasma-infected mothers to search for signs of early postnatal development disorders. During the first year of life, a slower postnatal motor development was observed in infants of mothers with latent toxoplasmosis. These infants significantly later developed the ability to control the head position (p=0.039), to roll from supine to prone position (p=0.022) and were slightly later to begin crawling (p=0.059). Our results are compatible with the hypothesis that the difference in the rates of prenatal and early postnatal development between children of Toxoplasma-negative and Toxoplasma-positive mothers might be caused by a decreased stringency of embryo quality control in partly immunosuppressed Toxoplasma-positive mothers resulting in a higher proportion of infants with genetic or developmental disorders in offspring. However, because of relatively low return rate of questionnaires and an associated risk of a sieve effect, our results should be considered as preliminary and performing a large scale prospective study in the future is critically needed.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22819214     DOI: 10.1016/j.earlhumdev.2012.07.001

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  8 in total

1.  Prenatal toxoplasmosis antibody and childhood autism.

Authors:  Marisa N Spann; Andre Sourander; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Alan S Brown
Journal:  Autism Res       Date:  2016-11-22       Impact factor: 5.216

2.  Fetomaternal and Pediatric Toxoplasmosis.

Authors:  Helieh S Oz
Journal:  J Pediatr Infect Dis       Date:  2017-12       Impact factor: 0.293

Review 3.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

4.  Influence of maternal infections on neonatal acute phase proteins and their interaction in the development of non-affective psychosis.

Authors:  Å Blomström; R M Gardner; C Dalman; R H Yolken; H Karlsson
Journal:  Transl Psychiatry       Date:  2015-02-03       Impact factor: 6.222

5.  Molecular Detection and Genotypic Characterization of Toxoplasma gondii in Paraffin-Embedded Fetoplacental Tissues of Women with Recurrent Spontaneous Abortion.

Authors:  Amir Abdoli; Abdolhossein Dalimi; Haleh Soltanghoraee; Fatemeh Ghaffarifar
Journal:  Int J Fertil Steril       Date:  2016-11-01

6.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

Review 7.  The Importance of IgG Avidity and the Polymerase Chain Reaction in Treating Toxoplasmosis during Pregnancy: Current Knowledge.

Authors:  João Bortoletti Filho; Edward Araujo Júnior; Natália da Silva Carvalho; Talita Micheletti Helfer; Priscila de Oliveira Nogueira Serni; Luciano Marcondes Machado Nardozza; Antonio Fernandes Moron
Journal:  Interdiscip Perspect Infect Dis       Date:  2013-09-26

Review 8.  Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon.

Authors:  Helieh S Oz
Journal:  Front Microbiol       Date:  2014-07-24       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.